{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T02:37:01Z","timestamp":1788230221062,"version":"build-2803163510"},"reference-count":22,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1597,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1111\/j.2040-1124.2011.00122.x","type":"journal-article","created":{"date-parts":[[2011,4,18]],"date-time":"2011-04-18T12:00:13Z","timestamp":1303128013000},"page":"457-463","source":"Crossref","is-referenced-by-count":28,"title":["Efficacy and safety evaluation of pregabalin treatment over 52\u2003weeks in patients with diabetic neuropathic pain extended after a double-blind placebo-controlled trial"],"prefix":"10.1111","volume":"2","author":[{"given":"Jo","family":"Satoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soroku","family":"Yagihashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamotsu","family":"Yoshiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,4,18]]},"reference":[{"key":"10.1111\/j.2040-1124.2011.00122.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"956","DOI":"10.2337\/diacare.28.4.956","article-title":"Diabetic neuropathies: a statement by the American Diabetes Association","volume":"28","author":"Boulton","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1111\/j.2040-1124.2011.00122.x-BIB2|cit2","first-page":"147","article-title":"Chronic pain in patients with diabetes mellitus: comparison with a non-diabetic population","volume":"3","author":"Chan","year":"1990","journal-title":"Pain Clin"},{"issue":"Suppl. 1","key":"10.1111\/j.2040-1124.2011.00122.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1016\/j.diabres.2007.01.054","article-title":"Pathology and pathogenetic mechanisms of diabetic neuropathy: correlation with clinical signs and symptoms","volume":"77","author":"Yagihashi","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1111\/j.2040-1124.2011.00122.x-BIB4|cit4","first-page":"1395","article-title":"Present state and future prospects of treatment of neuropathic pain in Japan: recommendations by the consensus conference between experts","volume":"30","author":"Hanaoka","year":"2009","journal-title":"Pain Clin"},{"key":"10.1111\/j.2040-1124.2011.00122.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1212\/01.wnl.0000282763.29778.59","article-title":"Neuropathic pain: redefinition and a grading system for clinical and research purposes","volume":"70","author":"Treede","year":"2008","journal-title":"Neurology"},{"key":"10.1111\/j.2040-1124.2011.00122.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1016\/j.euroneuro.2006.04.005","article-title":"Pregabalin: from molecule to medicine","volume":"16","author":"Kavoussi","year":"2006","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1111\/j.2040-1124.2011.00122.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/syn.10094","article-title":"Preferential action of gabapentin and pregabalin at P\/Q-type voltage-sensitive calcium channels: inhibition of K+-evoked [3H]-norepinephrine release from rat neocortical slices","volume":"45","author":"Dooley","year":"2002","journal-title":"Synapse"},{"key":"10.1111\/j.2040-1124.2011.00122.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","article-title":"Pharmacologic management of neuropathic pain: evidence-based recommendations","volume":"132","author":"Dworkin","year":"2007","journal-title":"Pain"},{"key":"10.1111\/j.2040-1124.2011.00122.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","article-title":"EFNS guidelines on pharmacological treatment of neuropathic pain: 2010 revision","volume":"17","author":"Attal","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1111\/j.2040-1124.2011.00122.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1464-5491.2010.03152.x","article-title":"Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14-week, randomized, double-blind, placebo-controlled trial","volume":"28","author":"Satoh","year":"2011","journal-title":"Diabet Med"},{"key":"10.1111\/j.2040-1124.2011.00122.x-BIB11|cit11","first-page":"225","article-title":"Simplified diagnostic criteria for distal symmetric polyneuropathy","volume":"14","author":"Diabetic Neuropathy Study Group","year":"2003","journal-title":"Peripher Nerve"},{"key":"10.1111\/j.2040-1124.2011.00122.x-BIB12|cit12","first-page":"9","article-title":"The development of a Japanese version of the short-form McGill pain questionnaire","volume":"14","author":"Yamaguchi","year":"2007","journal-title":"J Jpn Soc Pain Clin"},{"key":"10.1111\/j.2040-1124.2011.00122.x-BIB13|cit13","first-page":"450","article-title":"The Research and Examination Committee on Diabetic Diagnosis Criteria. Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus","volume":"53","author":"Seino","year":"2010","journal-title":"J Jpn Diabetes Soc"},{"key":"10.1111\/j.2040-1124.2011.00122.x-BIB14|cit14","first-page":"93","volume-title":"Evidence-based Guidelines on Clinical Practice for Diabetes","author":"Japan Diabetes Society","year":"2007"},{"key":"10.1111\/j.2040-1124.2011.00122.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2377-8-33","article-title":"Efficacy and safety of pregabalin 600mg\/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial","volume":"8","author":"Arezzo","year":"2008","journal-title":"BMC Neurol"},{"key":"10.1111\/j.2040-1124.2011.00122.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.pain.2004.05.001","article-title":"Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial","volume":"110","author":"Rosenstock","year":"2004","journal-title":"Pain"},{"key":"10.1111\/j.2040-1124.2011.00122.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejpain.2007.05.003","article-title":"Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study","volume":"12","author":"T\u00f6lle","year":"2008","journal-title":"Eur J Pain"},{"key":"10.1111\/j.2040-1124.2011.00122.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jpain.2004.12.007","article-title":"Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial","volume":"6","author":"Richter","year":"2005","journal-title":"J Pain"},{"key":"10.1111\/j.2040-1124.2011.00122.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1212\/01.WNL.0000145767.36287.A1","article-title":"Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial","volume":"63","author":"Lesser","year":"2004","journal-title":"Neurology"},{"key":"10.1111\/j.2040-1124.2011.00122.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.pain.2005.02.032","article-title":"Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens","volume":"115","author":"Freynhagen","year":"2005","journal-title":"Pain"},{"key":"10.1111\/j.2040-1124.2011.00122.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"J Pain"},{"key":"10.1111\/j.2040-1124.2011.00122.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2147\/CIA.S1681","article-title":"Pharmacological treatment of neuropathic pain in older persons","volume":"3","author":"Haslam","year":"2008","journal-title":"Clin Interv Aging"}],"container-title":["Journal of Diabetes Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.2040-1124.2011.00122.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.2040-1124.2011.00122.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T20:18:55Z","timestamp":1625602735000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.2040-1124.2011.00122.x"}},"subtitle":["Long-term treatment with pregabalin"],"short-title":[],"issued":{"date-parts":[[2011,4,18]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"URL":"https:\/\/doi.org\/10.1111\/j.2040-1124.2011.00122.x","relation":{},"ISSN":["2040-1116"],"issn-type":[{"value":"2040-1116","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4,18]]}}}